发明名称 |
Methods for increasing adiponectin |
摘要 |
In certain aspects, the present invention provides compositions and methods for increasing adiponectin in a patient in need thereof by administering an antagonist of an ActRIIB signaling pathway. Examples of such antagonists include ActRIIB polypeptides, anti-ActRIIB antibodies, anti-activin A and/or B antibodies, anti-myostatin antibodies, anti-GDF3 antibodies, and anti-BMP7 antibodies. Also provided are methods for ameliorating one or more undesired effects of anti-androgen therapy, including muscle loss, bone loss, increased adiposity, and/or increased insulin resistance. A variety of disorders may be treated by causing an increase in circulating adiponectin concentrations. |
申请公布号 |
US8765663(B2) |
申请公布日期 |
2014.07.01 |
申请号 |
US201213404593 |
申请日期 |
2012.02.24 |
申请人 |
Acceleron Pharma Inc. |
发明人 |
Seehra Jasbir;Kumar Ravindra;Lachey Jennifer;Koncarevic Alan |
分类号 |
A61K38/00;A61K39/00;A61K39/395 |
主分类号 |
A61K38/00 |
代理机构 |
Ropes & Gray LLP |
代理人 |
Ropes & Gray LLP |
主权项 |
1. A method for increasing adiponectin in a patient in need thereof, the method comprising administering an effective amount of an antibody, or antigen-binding fragment thereof, that specifically binds to an activin type IIB receptor (ActRIIB), and wherein the antibody, or antigen-binding fragment thereof, inhibits one or more of activin A, GDF8, and GDF11 from binding to the ActRIIB. |
地址 |
Cambridge MA US |